期刊文献+
共找到2,378篇文章
< 1 2 119 >
每页显示 20 50 100
Efficacy ofβ2-adrenergic receptor agonist combined with corticosteroid in the treatment of children with cough variant asthma
1
作者 Jun-Yi Cao Ying-Chun Wang Xiao-Xia Deng 《World Journal of Clinical Cases》 SCIE 2023年第31期7610-7618,共9页
BACKGROUND Cough variant asthma(CVA)is one of the most common respiratory diseases in children,which has a serious impact on the quality of life and daily activities of children.For severe CVA,immunomodulatory drugs a... BACKGROUND Cough variant asthma(CVA)is one of the most common respiratory diseases in children,which has a serious impact on the quality of life and daily activities of children.For severe CVA,immunomodulatory drugs are needed.AIM To evaluate the efficacy of salmeterol combined with budesonide in the treatment of pediatric CVA.METHODS 130 children with CVA from January 2020 to December 2022 were prospectively selected and randomly divided into an observation group(salmeterol combined with budesonide)and a control group(budesonide combined with a placebo).Compare the clinical efficacy of two groups before and after intervention.The evaluation parameters include cough frequency score,nocturnal cough arousal,and lung function indicators.Serum inflammatory markers,immune function markers and airway anatomical indicators were also measured.RESULTS After the intervention,the total effective rate of the observation group was significantly higher than that of the control group,and the cough frequency score and the night cough wake rate of the observation group were lower than that of the control group,with a statistically significant difference.In addition,the changes of lung function indicators,serum markers and immune function markers in the observation group were better than those in the control group.CONCLUSION The clinical efficacy of salmeterol combined with Budesonide in the treatment of CVA is better than that of Budesonide alone. 展开更多
关键词 SALMETEROL BUDESONIDE cough variant asthma PEDIATRICS Efficacy analysis
下载PDF
Experimental study on the regulation effect of Qiaoqin Qingfei agent on cough variant asthma based on airway neurogenic inflammation
2
作者 HUANG Hui-si HAN Chao +4 位作者 SHI Yan-hong QI Chun-li XIONG Ai-hua ZHANG Qiuling LIANG Hui-ling 《Journal of Hainan Medical University》 CAS 2023年第9期25-32,共8页
Objective:To investigate the mechanism of regulation of airway neurogenic inflammation by Qiaoqin Qingfei agent in rats with cough variant asthma(CVA).Methods:48 SD rats were randomly divided into blank group,model gr... Objective:To investigate the mechanism of regulation of airway neurogenic inflammation by Qiaoqin Qingfei agent in rats with cough variant asthma(CVA).Methods:48 SD rats were randomly divided into blank group,model group,montelukast sodium group(1.05 mg/kg)and high,medium and low dose groups(26,13,6.5 g/kg),with 8 rats in each group.The rat CVA model was established by the method of ovalbumin(OVA)combined with aluminum hydroxide(Al(OH)3)sensitization and repeated stimulation.From the second day of sensitization,the rat CVA model was given by gavage for 28 days.The pathological changes of lung tissue were observed under microscope by HE staining.The content changes of nerve growth factor(NGF)and substance P(SP)in alveolar lavage fluid(BALF)were determined by double-antibody sandwich ABC-ELISA,and the protein expression levels of NGF and SP in lung tissue were detected by immunohistochemistry.Results:Pathological findings showed significant inflammatory manifestations in the model group,and the inflammatory infiltration in the high-dose,medium-dose and low-dose groups of Qiaoqin Qingfei agent and montelukast sodium groups were alleviated to varying degrees.Compared with blank group,the protein expression levels of NGF and SP in lung tissue of model group were significantly increased(P<0.01).Compared with model group,the protein expression levels of NGF and SP in lung tissue and the contents of NGF and SP in alveolar lavage fluid in high-dose,medium-dose and low-dose groups and montelukast sodium group were significantly decreased(P<0.05).Conclusion:Qiaoqin Qingfei agent may reduce airway inflammation and relieve cough variant asthma by regulating the protein expression levels of NGF and SP in airway neurogenic inflammation. 展开更多
关键词 Qiaoqin Qingfei agent cough variant asthma Airway neurogenic inflammation Nerve growth factor Substance P
下载PDF
Effect of glycyrrhetinic acid on Th1/Th2 balance in cough variant asthma mice
3
作者 CHEN Qiu-ling ZHOU Bei +3 位作者 LI Yan-ling LIN Hui WU Yan-chun LIU Han 《Journal of Hainan Medical University》 CAS 2023年第16期1-6,共6页
Objective:To evaluate the therapeutic effect of Glycyrrhetinic Acid on cough variant asthma(CVA)mice and to investigate the possible mechanism in reducing lung inflammation.Methods:48 young female Balb/c mice were div... Objective:To evaluate the therapeutic effect of Glycyrrhetinic Acid on cough variant asthma(CVA)mice and to investigate the possible mechanism in reducing lung inflammation.Methods:48 young female Balb/c mice were divided into Control,CVA,Prednisone Acetate,Glycyrrhetinic Acid high-dose,Glycyrrhetinic Acid middle-dose and Glycyrrhetinic Acid lowdose groups randomly,with 8 mice in each group.The CVA mice model was established by ovalbumin(OVA)sensitization and OVA challenge,the animal asthma behavior was observed after drug administration,and the index of the lung of mice were recorded.The level of OVAsIgE in the bronchoalveolar lavage fluid(BALF)was tested by ELISA.The pathological changes of the lung tissue were observed by Hematoxylin and Eosin(H&E)staining.The protein expressions of T-bet,IFN-γ,Gata3,IL-4 and IL-13 in the lung tissue were determined by Western blot.Results:Compared with the CVA group,the index of lung of mice,the OVA-sIgE level in BALF and expression levels of Th2-related factor in the lung tissue of mice in Prednisone Acetate and Glycyrrhetinic Acid groups were significantly decreased(P<0.05 or P<0.01),the infiltration of inflammatory cells in the lung tissue was reduced,while expressions of Th1-related factor in the lung tissue was significantly increased(P<0.05 or P<0.01).Conclusion:Glycyrrhetinic acid has therapeutic effect on CVA mice,the underlying mechanism of Glycyrrhetinic acid alleviating lung impairment and airway inflammation may be associated with mediating the Th1/Th2 imbalance in the lung tissue. 展开更多
关键词 Glycyrrhetinic acid cough variant asthma(CVA) Th1/Th2 Balance
下载PDF
Clinical Analysis of Dispelling Wind,Eliminating Lung and Relieving Cough Combined with Western Medicine in the Treatment of Cough Variant Asthma in Children 被引量:3
4
作者 He Huang 《Journal of Clinical and Nursing Research》 2021年第5期136-141,共6页
Objective:This study mainly explores the clinical effect of dispelling wind,eliminating lung and relieving cough combined with western medicine in the treatment of cough variant asthma.Methods:80 children with cough v... Objective:This study mainly explores the clinical effect of dispelling wind,eliminating lung and relieving cough combined with western medicine in the treatment of cough variant asthma.Methods:80 children with cough variant asthma accepted by our hospital from January 2018 to December 2020 were randomly selected for the study and divided into two groups.One group was the reference group(40 cases)treated with procaterol hydrochloride tablets and montelukast sodium,and the other group was the research group(40 cases)・The method of eliminating wind,eliminating lung and relieving cough was combined with procaterol hydrochloride tablets and montelukast sodium to observe and compare the curative effects of the two groups.Results:There was no significant difference in TCM symptom score and eosinophil(EOS)count between the two groups before treatment(P>0.05);After treatment,the TCM symptom scores of coughs,pharyngeal itching,expectoration,nasal congestion and nasal itching in the research group were lower than those in the reference group,and the EOS count was lower than that in the reference group(P<0.05);The effective rate of research group was higher than that of reference group(P<0.05).Conclusions:For children with cough variant asthma,Qufeng Sufei cough relieving method combined with procaterol hydrochloride and montelukast sodium can improve children's symptoms and reduce eosinophil count. 展开更多
关键词 Dispelling wind Eliminating lung and relieving cough Procaterol hydrochloride Montelukast sodium CHILDREN cough variant asthma Clinical effect
下载PDF
The influence of vitamin D3 on airway inflammation and osteopontin expression in cough variant asthma rats
5
作者 Jian-Wei Gu Yun Li +2 位作者 Yun-Feng Yang Yao-Dan Zhang Ju-Hua Liu 《Journal of Hainan Medical University》 2020年第10期33-37,共5页
Objective:To observe the effect of vitaminD3 on airway inflammation and osteopontin(OPN)expression on cough variant asthma(CVA)models.Methods:SD rats were randomly divided into blank group,model group and treatment gr... Objective:To observe the effect of vitaminD3 on airway inflammation and osteopontin(OPN)expression on cough variant asthma(CVA)models.Methods:SD rats were randomly divided into blank group,model group and treatment group,each group with 10 rats.The CVA model was induced by intraperitoneal injection combined with aerosolized ovalbumin(OVA),the treatment group was given 100 mg/ml of vitaminD330 minutes before challenge by administered orally.Airway hyperreaction were measured by airway resistance after inhalation of acetylcholine(Ach).Wright-Gimsa staining was used to observe the inflammatory cells in bronchoalveolar lavage fluid(BALF).HE and PAS were used to observe the morphological changes of lung tissue.OPN expression was detected by immunohistochemistry.Results:1)Airway hyperreaction:airway resistance after inhalation Ach in model group and treatment group were significantly higher than that in blank group(P<0.01),airway resistance in treatment group were lower than that in model group(P<0.01);2)Classification of inflammatory cells:The percentage of macrophages,lymphocytes,neutrophils,and eosinophils in the BALF of the model group and the treatment group were increased compared with the blank group(P<0.01),furthermore,the number of treatment group were lower than the model group(P<0.05);3)Morphological changes of lung tissue:a large amount of inflammatory cells and goblet cell proliferation were observed in the lung tissue of the model group,and these changes were slight in treatment group compared with model group;OPN expression in lung tissue:The expression of OPN in model and treatment group were increased compared with blank group(P<0.05),and the treatment group was lower than that of model group(P<0.05).The OPN content was positively correlated with the percentage of inflammatory cells in BALF(P<0.05).Conclusions:Vitamin D3 can reduce airway hyperreaction and airway inflammation in CVA rats.The mechanism may be related to the intervention of OPN expression in lung tissue. 展开更多
关键词 Vitamin D cough variant asthma OSTEOPONTIN Airway hyperreaction Airway inflammation
下载PDF
Meta-analysis of the efficacy and safety of Ding-Chuan Tang in the treatment of pediatric cough variant asthma
6
作者 Wen Zhang Hai-Tao Zheng Shu-Xia Ma 《Clinical Research Communications》 2022年第1期5-19,共15页
Objective:To systematically evaluate the clinical efficacy and safety of Ding-Chuan Tang in the treatment of pediatric cough variant asthma(CVA).Methods:Randomized controlled trials on the treatment of pediatric CVA w... Objective:To systematically evaluate the clinical efficacy and safety of Ding-Chuan Tang in the treatment of pediatric cough variant asthma(CVA).Methods:Randomized controlled trials on the treatment of pediatric CVA with Ding-Chuan Tang were searched by computer through the China Journal Full Text Database(CNKI),WanFang Digital Journal Full Text Database(WanFang Data),Vipe Chinese Science and Technology Journal Database(VIP),Pubmed Database,Ovid Database,Embase Database,etc.The search time was from database establishment to April 1,2021.Based on the inclusion and exclusion criteria,the Executive editor:Nuo-Xi Pi.Received:10 September 2021;Accepted:13 January 2022;Available online:19 January 2022.©2022 By Author(s).Published by TMR Publishing Group Limited.This is an open access article under the CC-BY license.(http://creativecommons.Org/licenses/BY/4.0/)two researchers independently screened the literature,extracted information,and assessed the methodological quality evaluation of the literature,and Meta-analysis was performed by RevMan 5.4 software.Results:The final number of RCTs was included 17,including cases of affected 1308 children.According to the results of the Meta-analysis:the test group was significantly better than the control group in terms of clinical efficiency,percentage of first second force expiratory volume(FEV1%),percentage of peak expiratory flow rate(PEF%),time to treatment onset,time to the disappearance of symptoms,Chinese medicine symptom score,and recurrence rate;the difference in the incidence of adverse reactions between the two groups was not statistically significant.Conclusion:The clinical treatment of pediatric CVA with Ding-Chuan Tang is effective and does not increase the incidence of adverse reactions.However,the methodological and reporting quality of existing small-sample randomized controlled trials(RCTs)is low,so evidence of efficacy must be confirmed by rigorously designed large-sample clinical trials. 展开更多
关键词 Ding-Chuan Tang pediatric cough variant asthma META-ANALYSIS systematic evaluation randomized controlled trial
下载PDF
The effectiveness and safety of HuangQiXiXin decoction for cough variant asthma:protocol for a systematic review
7
作者 Qing-Qing Xia Cong Wang +2 位作者 Yu-Feng Zhang Wei-Long Jiang Jia Qi 《Clinical Research Communications》 2022年第2期5-8,共4页
Objective:A comprehensive and updated systematic review is needed to evaluate the effectiveness and safety of HuangQiXiXin decoction(HQXXD)for cough variant asthma(CVA).The aim of this systematic review protocol is to... Objective:A comprehensive and updated systematic review is needed to evaluate the effectiveness and safety of HuangQiXiXin decoction(HQXXD)for cough variant asthma(CVA).The aim of this systematic review protocol is to comprehensively assess the effectiveness and safety of HQXXD for CVA.Methods:An overall search for studies in main English and Chinese electronic databases from their inception to January 2021 will be performed.Randomized controlled trials regarding HQXXD for CVA will be included.We will use RevMan 5.3 software to perform statistical analysis and meta-analysis.Results:The findings of this systematic review will be disseminated through peer-reviewed publications.Conclusion:The systematic review will provide more evidence regarding the effectiveness and safety of HQXXD for CVA. 展开更多
关键词 HuangQiXiXin decoction cough variant asthma PROTOCOL systematic review
下载PDF
Effectiveness and safety of traditional Chinese herbs in children with cough variant asthma: a systematic review and Meta-analysis 被引量:6
8
作者 Kyou-Hwan Han Ki Haeng Cho +2 位作者 CUI Shanqin Lily Lin Jaejong Kim 《Journal of Traditional Chinese Medicine》 SCIE CSCD 2021年第5期661-668,共8页
OBJECTIVE:To systematically investigate the clinical effectiveness and safety of traditional Chinese herbs(TCHs)as an alternative to conventional medicine(CM)in children with cough variant asthma(CVA).METHODS:Randomiz... OBJECTIVE:To systematically investigate the clinical effectiveness and safety of traditional Chinese herbs(TCHs)as an alternative to conventional medicine(CM)in children with cough variant asthma(CVA).METHODS:Randomized controlled trial(RCT)studies that were published from their inceptions to March 31,2020,were identified from the electronic databases of China National Knowledge Infrastructure,Wangfang,Pub Med,and Cochrane Central Library.The primary outcome of the review was the total effective rate(TER),and the secondary outcomes were immunoglobulin E(Ig E),peak expiratory flow(PEF),adverse drug reactions,and relapse rates of interventions.RESULTS:For the Meta-analysis,13 studies involving 992 children with CVA were included.In terms of TER and Ig E,the experimental interventions of TCH,when compared with the control interventions of CM,on pediatric CVA were found to be significantly effective(P<0.0001),whereas for spirometry,PEF was not significantly improved in the TCH group(P=0.48).The incident rates of adverse drug reaction and relapse were found to be significantly lower in the TCH group than those in the CM group(P=0.02 and P<0.0001,respectively).CONCLUSION:Compared with CM therapy,the effects of TCH therapy on pediatric CVA were significantly beneficial in terms of TER and Ig E,but not for PEF,and the methodological quality of included studies was poor.Therefore,the results should be interpreted with caution.More randomized controlled trials with rigorous experimental methodologies are required for objectivity in the future. 展开更多
关键词 cough variant asthma CHILD drugs Chinese herbal randomized controlled trial systematic review META-ANALYSIS
原文传递
Clinical Study on Treatment of Cough Variant Asthma by Chinese Medicine 被引量:17
9
作者 苗青 魏鹏草 +1 位作者 樊茂蓉 张燕萍 《Chinese Journal of Integrative Medicine》 SCIE CAS 2013年第7期539-545,共7页
目的将在对待咳嗽变体气喘(CVA ) 观察临床的功效和中国药(厘米) 的航线应答的变化。证实了 CVA 的诊断的 94 个病人被选择并且随机由堵住的随机化方法分到治疗组和控制组的方法。二个组的比率是 2:1。治疗组有被厘米对待的 63 个病人,... 目的将在对待咳嗽变体气喘(CVA ) 观察临床的功效和中国药(厘米) 的航线应答的变化。证实了 CVA 的诊断的 94 个病人被选择并且随机由堵住的随机化方法分到治疗组和控制组的方法。二个组的比率是 2:1。治疗组有被厘米对待的 63 个病人,在 10 种情况中输了, 53 个病人完成了审判。控制组有被 montelukast 药片和 theophylline 对待的 31 个病人,在 5 种情况中输了, 26 个病人完成了审判,二个星期作为一堂治疗学的功课。在二个组之间的症候群功效,咳嗽功效,症状分数和航线应答被观察。结果症候群功效的比较:治疗组的全部的有效的率是 90.57% ,控制组是 76.92% ,和二组是显著地不同的(P < 0.05 ) 。咳嗽功效的比较:治疗组的全部的有效的率是 98.11% ,控制组是 80.77% ,和二组也是显著地不同的(P < 0.05 ) 。症候群得分和咳嗽得分都显著地显著地被降低,但是航线应答不是降低。厘米的治疗能减轻咳嗽的结论,改进明显的优点与控制相比组织的症候群,和表演,它值得广泛的临床的申请。 展开更多
关键词 临床疗效 治疗 咳嗽 哮喘 异性 中医药 气道反应性 对照组
原文传递
A Brief Analysis on the Characteristics of Chinese Medicine and Treatment for Cough Variant
10
作者 Yuntao Duan Junming Hou +1 位作者 Yang Hui Dezhen Yang 《Journal of Clinical and Nursing Research》 2021年第4期70-72,共3页
Cough variant is a common disease of the respiratory system and can lead to a unique type of asthma.The disease has no obvious symptoms such as wheezing nor shortness of breath.Coughing is the main clinical symptom,as... Cough variant is a common disease of the respiratory system and can lead to a unique type of asthma.The disease has no obvious symptoms such as wheezing nor shortness of breath.Coughing is the main clinical symptom,as it causes airway hyper-responsiveness.Traditional Chinese medicine(TCM)has a unique understanding of this disease,and the effect is obvious after treatment,as it's based on symptom differentiation.This article takes the concept of“mild fluid retention”from“The Synopsis of the Golden Chamber”as an entry point,briefly describes the relationship between cough variant and mild fluid retention,as well as the diagnosis and treatment of Chinese medicine. 展开更多
关键词 cough variant asthma cough Mild fluid retention Resolving fluid retention with warm medicine
下载PDF
咳嗽变异性哮喘患儿血清25(OH)D_(3)、IL-6水平变化与T淋巴细胞免疫平衡的关系及预测预后的价值分析
11
作者 张洲慧 张彤 +2 位作者 李燕茹 李红霞 赵华昌 《标记免疫分析与临床》 CAS 2024年第4期670-674,762,共6页
目的分析咳嗽变异性哮喘(CVA)患儿血清25-羟维生素D_(3)[25(OH)D_(3)]、白介素-6(IL-6)水平变化与T淋巴细胞免疫平衡的关系及预测预后的价值。方法选取98例CVA患儿作为研究组,49例健康儿童作为对照组。比较两组一般资料、血清25(OH)D_(3... 目的分析咳嗽变异性哮喘(CVA)患儿血清25-羟维生素D_(3)[25(OH)D_(3)]、白介素-6(IL-6)水平变化与T淋巴细胞免疫平衡的关系及预测预后的价值。方法选取98例CVA患儿作为研究组,49例健康儿童作为对照组。比较两组一般资料、血清25(OH)D_(3)、IL-6水平、T淋巴细胞免疫平衡指标,分析研究组血清25(OH)D_(3)、IL-6水平与免疫平衡指标的相关性,比较治疗4周后不同预后患儿治疗前后血清25(OH)D_(3)、IL-6水平及变化值(以△表示治疗前后变化值的绝对值),分析△25(OH)D_(3)、△IL-6与预后的相关性及治疗前血清25(OH)D_(3)、IL-6预测预后的价值。结果研究组血清25(OH)D_(3)水平、外周血CD4^(+)T淋巴细胞百分比低于对照组,血清IL-6水平高于对照组(P<0.05);研究组血清25(OH)D_(3)水平与外周血CD4^(+)T淋巴细胞百分比呈正相关,血清IL-6水平与外周血CD4^(+)T淋巴细胞百分比呈负相关(P<0.05);预后不良患儿治疗前、治疗后血清25(OH)D_(3)水平低于预后良好患儿,IL-6水平高于预后良好患儿,△IL-6小于预后良好患儿(P<0.05);研究组△IL-6与预后呈正相关(P<0.05);治疗前血清25(OH)D_(3)、IL-6单独预测CVA患儿预后不良的曲线下面积(AUC)分别为0.784、0.764,与单独预测比较,联合预测的AUC(0.926)明显增大,NRI、IDI均>0(P<0.05)。结论CVA患儿血清25(OH)D_(3)、IL-6水平变化与T淋巴细胞免疫平衡失调有关,且各指标联合在预测患儿预后方面具有良好应用价值。 展开更多
关键词 咳嗽变异性哮喘 免疫平衡 预后 25-羟维生素D_(3) 炎性因子
下载PDF
温润辛金方治疗微寒恋肺型咳嗽变异型哮喘的临床疗效研究
12
作者 高金柱 苗青 +1 位作者 樊茂蓉 丛晓东 《中国合理用药探索》 CAS 2024年第2期101-106,共6页
目的:观察温润辛金方治疗微寒恋肺型咳嗽变异型哮喘(CVA)的临床疗效及安全性,为CVA的中医临床治疗提供依据和思路。方法:选取2017年6月~2019年12月期间于某院就诊的60例微寒恋肺型CVA患者,根据随机数字表法分为对照组和观察组,每组30例... 目的:观察温润辛金方治疗微寒恋肺型咳嗽变异型哮喘(CVA)的临床疗效及安全性,为CVA的中医临床治疗提供依据和思路。方法:选取2017年6月~2019年12月期间于某院就诊的60例微寒恋肺型CVA患者,根据随机数字表法分为对照组和观察组,每组30例。对照组给予沙美特罗替卡松吸入粉雾剂,观察组给予温润辛金方,两组均治疗6周。观察两组患者的中医证候疗效以及不良反应,比较两组患者治疗前后呼出气一氧化氮(FeNO)及咳嗽症状积分的变化。结果:对照组和观察组分别脱落2例和4例。两组临床治疗总有效率比较无统计学差异(P>0.05)。治疗后,两组咳嗽症状积分、FeNO均较治疗前下降(P<0.05),且观察组咳嗽症状积分低于对照组(P<0.05),但两组FeNO水平比较无统计学差异(P>0.05)。观察组有2例患者在服药期间出现恶心等胃部不适,嘱其改为饭后服药后症状消失;对照组有2例患者出现轻微不良反应,但不影响后续治疗。结论:温润辛金方可有效改善微寒恋肺型CVA患者的临床症状和咳嗽症状积分,临床疗效较佳且安全性良好。 展开更多
关键词 温润辛金方 微寒恋肺 咳嗽变异型哮喘 呼出气一氧化氮 咳嗽症状积分
下载PDF
基于网络药理学探讨紫苏子—杏仁药对治疗咳嗽变异性哮喘的作用机制
13
作者 王卉 赵克明 《临床合理用药杂志》 2024年第10期14-18,共5页
目的 基于网络药理学探讨紫苏子—杏仁药对治疗咳嗽变异性哮喘(CVA)的潜在分子作用靶点及机制。方法 采用中药系统药理学数据库和分析平台(TCMSP)数据库对紫苏子—杏仁药对的有效活性成分进行筛选,并采用SwissTargetPrediction网站进行... 目的 基于网络药理学探讨紫苏子—杏仁药对治疗咳嗽变异性哮喘(CVA)的潜在分子作用靶点及机制。方法 采用中药系统药理学数据库和分析平台(TCMSP)数据库对紫苏子—杏仁药对的有效活性成分进行筛选,并采用SwissTargetPrediction网站进行靶点预测。采用GeneCards数据库检索CVA相关靶点,借助Venny 2.1.0获取交集靶点,对交集靶点分别运用Cytoscape 3.9.1软件和STRING数据库构建主要活性成分—潜在治疗靶基因网络图和PPI蛋白互作网络,并筛选出关键有效活性成分和核心靶蛋白,通过DAVID数据库对交集靶点进行GO功能及KEGG通路的富集分析。结果 筛选出紫苏子—杏仁药对有效成分19个,与CVA相关靶点224个,核心靶点为AKT1、IL-6、TP53、SRC、MAPK3、EGFR、JUN、PTGS2、HSP90AA1、ESR1。GO功能富集分析显示分子功能165个、细胞组分79个、生物过程630个。KEGG通路富集分析显示得到信号通路155条,主要涉及cAMP信号通路、PI3K-Akt信号通路、癌症通路、化学致癌—受体激活通路、神经活性配体—受体相互作用等。结论 紫苏子—杏仁药对可通过多成分、多靶点、多通路的协同作用抗CVA。 展开更多
关键词 咳嗽变异性哮喘 紫苏子 杏仁 网络药理学
原文传递
伏虎平咳饮对咳嗽变异性哮喘大鼠血清 IL-4、IL-10、TGF-β1影响的实验研究
14
作者 仇志锴 于映霞 李会影 《中国中医药科技》 CAS 2024年第2期203-205,共3页
目的:探讨伏虎平咳饮对咳嗽变异性哮喘大鼠的作用机制。方法:选取60只幼龄SD大鼠,根据体质量随机分为6组,正常对照组,模型对照组,伏虎平咳饮高、中、低剂量组及阳性对照组(布地奈德),给药2周后,ELISA测定各组大鼠血清白细胞介素-4(IL-4... 目的:探讨伏虎平咳饮对咳嗽变异性哮喘大鼠的作用机制。方法:选取60只幼龄SD大鼠,根据体质量随机分为6组,正常对照组,模型对照组,伏虎平咳饮高、中、低剂量组及阳性对照组(布地奈德),给药2周后,ELISA测定各组大鼠血清白细胞介素-4(IL-4)、白细胞介素-10(IL-10)、转化生长因子-β1(TGF-β1)的含量。结果:与正常对照组比较,模型对照组大鼠血清IL-4水平升高,IL-10、TGF-β的含量降低,均有显著性差异(P<0.01);与模型对照组比较,伏虎平咳饮高剂量组大鼠血清IL-4含量明显降低(P<0.01),IL-10含量明显升高(P<0.01),TGF-β含量升高(P<0.05)。结论:伏虎平咳饮能够通过升高咳嗽变异性哮喘大鼠血清IL-10、TGF-β1水平,降低血清IL-4水平,减轻气道炎症反应。 展开更多
关键词 伏虎平咳饮 咳嗽变异性哮喘 IL-4 IL-10 TGF-Β1 大鼠
下载PDF
宣肺化湿止咳汤联合西药治疗咳嗽变异性哮喘临床观察
15
作者 丁兆辉 许媛 +1 位作者 林新兴 万丽玲 《中国中医药现代远程教育》 2024年第10期133-136,共4页
目的研究宣肺化湿止咳汤治疗咳嗽变异性哮喘的临床效果及对呼出气一氧化氮(FeNO)数值的影响。方法选择2018年7月—2019年12月收治的120例咳嗽变异性哮喘患者作为研究对象,40例采用沙美特罗替卡松粉(舒利迭)吸入治疗作为西药组,40例采用... 目的研究宣肺化湿止咳汤治疗咳嗽变异性哮喘的临床效果及对呼出气一氧化氮(FeNO)数值的影响。方法选择2018年7月—2019年12月收治的120例咳嗽变异性哮喘患者作为研究对象,40例采用沙美特罗替卡松粉(舒利迭)吸入治疗作为西药组,40例采用宣肺化湿止咳汤治疗作为中药组,最后40例采用二者联合治疗作为联合组。观察三组治疗效果、咳嗽症状积分、FeNO水平、咳嗽生活质量以及不良反应情况。结果联合组的治疗总有效率为97.5%(39/40),明显高于西药组的80.0%(32/40)、中药组的82.5%(33/40),差异有统计学意义(P<0.05);治疗后联合组FeNO水平低于西药组和中药组,莱切斯特咳嗽问卷(LCQ)评分高于西药组和中药组,日间积分与夜间积分均低于西药组和中药组,差异均有统计学意义(P<0.05);西药组和中药组FeNO水平、LCQ评分、日间积分与夜间积分对比,差异无统计学意义(P>0.05)。结论宣肺化湿止咳汤联合西药治疗咳嗽变异性哮喘,效果较好,能明显减轻患者临床症状,提高生活质量,降低炎症反应,值得临床应用及推广。 展开更多
关键词 咳嗽 咳嗽变异性哮喘 宣肺化湿止咳汤 呼出气一氧化氮 中西结合疗法
下载PDF
小儿咳嗽变异性哮喘标准治疗后停药1年复发的影响因素及其交互效应
16
作者 马晓红 曹赋 +1 位作者 欧远贵 邓燕艺 《临床肺科杂志》 2024年第2期195-201,共7页
目的研究咳嗽变异性哮喘(CVA)患儿标准治疗后停药一年复发的影响因素及其交互效应。方法回顾性分析2018年1月-2020年1月玉林市红十字会医院收治的167例CVA患儿的临床资料,所有患儿均接受吸入性糖皮质激素(ICS)规范治疗(疗程≥6个月),停... 目的研究咳嗽变异性哮喘(CVA)患儿标准治疗后停药一年复发的影响因素及其交互效应。方法回顾性分析2018年1月-2020年1月玉林市红十字会医院收治的167例CVA患儿的临床资料,所有患儿均接受吸入性糖皮质激素(ICS)规范治疗(疗程≥6个月),停药后随访观察≥2年,按照患儿2年的随访结果,将CVA标准治疗后停药1年复发的98例患儿纳为CVA复发组,69例未复发纳为CVA未复发组,进行对照研究,分析CVA复发影响因素及其交互效应。结果单因素分析得出两组患儿反复呼吸道感染病史、变应性鼻炎、过敏性皮炎及停药时呼出气一氧化氮(FeNO)比较,差异有统计学意义(P<0.05)。多因素分析得出,有反复呼吸道感染病史(OR=4.543,P=0.001)、有变应性鼻炎(OR=7.146,P<0.001)、FeNO>20.00 ppb(OR=3.770,P=0.001)为CVA标准治疗后停药一年复发独立危险因素。反复呼吸道感染病史与变应性鼻炎、反复呼吸道感染病史与FeNO、变应性鼻炎与FeNO的交互作用指数S分别为2.152、1.527、1.397。结论有反复呼吸道感染、变应性鼻炎和FeNO>20.00ppb均是影响CVA标准治疗后停药1年复发的影响因素,且两两因素间有正向交互作用。 展开更多
关键词 小儿咳嗽变异性哮喘 复发 影响因素 交互效应
下载PDF
咳嗽变异性哮喘的中医药诊治进展 被引量:1
17
作者 赵琼 李兴芳 +3 位作者 魏文海 宋元泽 董敏 安丽萍 《西部中医药》 2024年第1期100-105,共6页
整理近年来中医药诊治咳嗽变异性哮喘(cough variant asthma,CVA)的相关文献发现,中医药治疗CVA疗效确切、副作用小,可有效缓解临床症状,改善患者肺功能。中医药治疗CVA虽然独具优势,但目前仍未形成统一中医病名和辨治体系,各家多依据... 整理近年来中医药诊治咳嗽变异性哮喘(cough variant asthma,CVA)的相关文献发现,中医药治疗CVA疗效确切、副作用小,可有效缓解临床症状,改善患者肺功能。中医药治疗CVA虽然独具优势,但目前仍未形成统一中医病名和辨治体系,各家多依据临床经验施治,以专方治疗多见,使得CVA在中医诊断、证候判定及遣方用药等方面缺乏规范性;其次,有关中医治疗CVA机制的研究较少;目前开展的临床研究多以小样本临床观察为主,缺乏高质量的循证医学证据,而且在适应症、禁忌症及不良反应方面的研究相对欠缺,未来可进一步规范CVA的中医病名、证候标准,拓宽CVA治疗思路。 展开更多
关键词 咳嗽变异性哮喘 中医治疗 综述
下载PDF
基于网络药理学和分子对接技术探究麻干平喘制剂治疗咳嗽变异性哮喘的作用机制
18
作者 李昀泽 任铭 +2 位作者 张颖 周子齐 李国信 《辽宁中医药大学学报》 CAS 2024年第4期199-206,共8页
目的利用网络药理学和分子对接技术探究麻干平喘制剂治疗咳嗽变异性哮喘的有效成分及其作用机制。方法在TCMSP、Herb数据库中查询麻干平喘制剂中各组成药物的活性成分,在GeneCards、OMIM数据库中对咳嗽变异性哮喘的疾病靶点进行搜索,筛... 目的利用网络药理学和分子对接技术探究麻干平喘制剂治疗咳嗽变异性哮喘的有效成分及其作用机制。方法在TCMSP、Herb数据库中查询麻干平喘制剂中各组成药物的活性成分,在GeneCards、OMIM数据库中对咳嗽变异性哮喘的疾病靶点进行搜索,筛选疾病与药物共同的靶点;使用Cytoscape软件绘制药物-活性成分-靶点-疾病网络,String数据库构建疾病-药物互作蛋白网络图;运用R语言和Perl计算机程序语言实现GO以及KEGG富集分析,并对关键靶点进行分子对接验证。结果得到药物靶点124个,疾病靶点3383个,筛选出麻干平喘制剂治疗咳嗽变异性哮喘的有效靶点80个;由PPI分析得出作用力最强的蛋白包括AKT1、CASP3、JUN、ESR1等;有效的疗效机制可能与TNF信号通路、IL-17信号通路、Th1和Th2细胞分化、PI3K-Akt信号通路等通路有关。分子对接显示:核心化合物槲皮素、甘草查尔酮A、山柰酚、芒柄花黄素与PPARG、AKT1、JUN、CASP3、STAT3有良好的结合活性。结论麻干平喘制剂可通过多靶点、多途径发挥治疗咳嗽变异性哮喘的疗效作用,为麻干平喘制剂的临床开发以及应用提供了有力的理论依据。 展开更多
关键词 网络药理学 分子对接 咳嗽变异性哮喘 麻干平喘制剂
原文传递
盐酸丙卡特罗联合消咳喘胶囊治疗儿童咳嗽变异性哮喘的临床疗效及对患儿血清学指标和气道功能的影响
19
作者 朱荷敏 王红宇 官晓艳 《新乡医学院学报》 CAS 2024年第1期60-64,70,共6页
目的探讨盐酸丙卡特罗联合消咳喘胶囊治疗儿童咳嗽变异性哮喘(CVA)的临床效果及对患儿血清学指标、气道功能的影响。方法选择2019年3月至2022年4月自贡市第一人民医院收治的124例CVA患儿为研究对象。采用随机数字表法将患儿分为对照组... 目的探讨盐酸丙卡特罗联合消咳喘胶囊治疗儿童咳嗽变异性哮喘(CVA)的临床效果及对患儿血清学指标、气道功能的影响。方法选择2019年3月至2022年4月自贡市第一人民医院收治的124例CVA患儿为研究对象。采用随机数字表法将患儿分为对照组和观察组,每组62例。对照组患儿给予盐酸丙卡特罗治疗,观察组患儿给予盐酸丙卡特罗联合消咳喘胶囊治疗,均治疗2周。比较2组患儿治疗后的临床疗效;分别于治疗前、治疗2周后评估2组患儿的日间和夜间咳嗽积分;分别于治疗前、治疗2周后采用酶联免疫吸附法检测2组患儿血清高迁移率族蛋白B1(HMGB1)、Toll样受体4(TLR4)、核因子κB(NF-κB)、白细胞介素-4(IL-4)、γ-干扰素(INF-γ)水平,并计算INF-γ/IL-4;应用肺功能检测仪测定2组患儿治疗前、治疗2周后的呼出25%肺活量时流速(MEF25)、呼出50%肺活量时流速(MEF50)和呼出75%肺活量时流速(MEF75);记录2组患儿治疗期间不良反应发生情况。结果对照组和观察组患儿的治疗总有效率分别为82.26%(51/62)、95.16%(59/62);观察组患儿治疗总有效率显著高于对照组(P<0.05)。治疗前2组患儿日间和夜间咳嗽积分比较差异无统计学意义(P>0.05);2组患儿治疗后日间和夜间咳嗽积分均显著低于治疗前(P<0.05);治疗后,观察组患儿日间和夜间咳嗽积分均显著低于对照组(P<0.05)。治疗前2组患儿血清HMGB1、TLR4、NF-κB水平比较差异无统计学意义(P>0.05);2组患儿治疗后血清HMGB1、TLR4、NF-κB水平显著低于治疗前(P<0.05);治疗后,观察组患儿血清HMGB1、TLR4、NF-κB水平显著低于对照组(P<0.05)。治疗前2组患儿MEF25、MEF50、MEF75比较差异无统计学意义(P>0.05);2组患儿治疗后MEF25、MEF50、MEF75显著高于治疗前(P<0.05);治疗后,观察组患儿MEF25、MEF50、MEF75显著高于对照组(P<0.05)。治疗前2组患儿血清IL-4、INF-γ水平及INF-γ/IL-4比较差异无统计学意义(P>0.05);2组患儿治疗后血清IL-4水平显著低于治疗前,INF-γ水平及INF-γ/IL-4显著高于治疗前(P<0.05);治疗后,观察组患儿血清IL-4显著低于对照组,INF-γ水平及INF-γ/IL-4显著高于对照组(P<0.05)。所有患儿治疗期间的药物耐受情况良好,未出现明显药物不良反应。结论消咳喘胶囊联合盐酸丙卡特罗治疗小儿CVA疗效显著,其作用机制可能与调控HMGB1-TLR4-NF-κB信号通路有关。 展开更多
关键词 儿童 咳嗽变异性哮喘 消咳喘胶囊 盐酸丙卡特罗 高迁移率族蛋白B1 TOLL样受体4 核因子-ΚB
下载PDF
中医药治疗儿童咳嗽变异性哮喘用药规律研究
20
作者 刘斯妤 郭凯 +1 位作者 沈湘晴 陈艳霞 《天津中医药大学学报》 CAS 2024年第4期307-312,共6页
[目的]通过古今医案云平台进行数据挖掘,分析中医药治疗儿童咳嗽变异性哮喘(CVA)的用药规律。[方法]全面检索自建库至2021年12月31日在中国生物医学文献服务系统(SinoMed)、中国知网(CNKI)、维普数据库(VIP)、万方数据知识服务平台(WanF... [目的]通过古今医案云平台进行数据挖掘,分析中医药治疗儿童咳嗽变异性哮喘(CVA)的用药规律。[方法]全面检索自建库至2021年12月31日在中国生物医学文献服务系统(SinoMed)、中国知网(CNKI)、维普数据库(VIP)、万方数据知识服务平台(WanFang)中收录的中医药治疗儿童CVA的相关文献,将相关中药处方导入Excel2018并建立标准化数据库,最后通过古今医案云平台软件进行频数分析、中药属性分析、关联规则分析、聚类分析等数据挖掘处理,分析中医药治疗儿童CVA的用药规律。[结果]研究共纳入文献190篇,录入方剂214首,合计中药203味。频数分析显示排名前10位的中药分别为苦杏仁、甘草、炙麻黄、半夏、地龙、蝉蜕、紫苏子、黄芩、桔梗、五味子,药性以温居多,药味以辛为首,归经以肺、脾、胃、肝为主。关联规则分析得出药物配伍规律26条,演化得到核心组合4组。[结论]现代中医药治疗儿童CVA多选用辛温之品,从肺、脾、胃出发,采用宣肺、祛痰、降气、平喘之法。 展开更多
关键词 咳嗽变异性哮喘 用药规律 数据挖掘 古今医案云平台
下载PDF
上一页 1 2 119 下一页 到第
使用帮助 返回顶部